Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Price

Showing results (431-440 of 489) with videos related to

Pageof 49
Sort By:
Molecular Cancer Therapeutics|October 14, 2003
Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assayGordon R Macpherson, Sylvia S W Ng, Siiri L Forbes, et al.
Urologia Internationalis|January 23, 2002
The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancerKelly J Cude, Jeffrey S Montgomery, Douglas K Price, et al.
Infancy : the Official Journal of the International Society on Infant Studies|June 20, 2025
Developmental Trajectories of Emotional Availability Differ Between Dyads With Children With and Without Motor DelayRebecca Molinini, Corri Stuyvenburg, Natalie A Koziol, et al.
Journal of Cellular and Molecular Medicine|May 13, 2025
Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian CancerZoe K Price, Noor A Lokman, Jessica Morrison, et al.
The Journal of Urology|April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancerWilliam D Figg, Sukyung Woo, Wenhui Zhu, et al.
Anticancer Research|August 30, 2023
<i>GNRH2</i> Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation TherapyTristan M Sissung, Sarah Lochrin, Tyler Liu, et al.
Molecular Cancer|April 30, 2014
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancerKelie M Reece, Emily D Richardson, Kristina M Cook, et al.
Circulation|December 13, 1997
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reactionK O Schowengerdt, J Ni, S W Denfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VIIA Wallgren, M Bonetti, R D Gelber, et al.
International Journal of Obesity (2005)|September 3, 2024
Metabolic adaptation following gastric bypass surgery: results from a 2-year observational studyFathimath Naseer, Shu-Dong Zhang, Alexander D Miras, et al.
Pageof 49

Showing results (431-440 of 489) with videos related to

Sort By:
Pageof 49
Molecular Cancer Therapeutics|October 14, 2003
Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assayGordon R Macpherson, Sylvia S W Ng, Siiri L Forbes, et al.
Urologia Internationalis|January 23, 2002
The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancerKelly J Cude, Jeffrey S Montgomery, Douglas K Price, et al.
Infancy : the Official Journal of the International Society on Infant Studies|June 20, 2025
Developmental Trajectories of Emotional Availability Differ Between Dyads With Children With and Without Motor DelayRebecca Molinini, Corri Stuyvenburg, Natalie A Koziol, et al.
Journal of Cellular and Molecular Medicine|May 13, 2025
Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian CancerZoe K Price, Noor A Lokman, Jessica Morrison, et al.
The Journal of Urology|April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancerWilliam D Figg, Sukyung Woo, Wenhui Zhu, et al.
Anticancer Research|August 30, 2023
<i>GNRH2</i> Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation TherapyTristan M Sissung, Sarah Lochrin, Tyler Liu, et al.
Molecular Cancer|April 30, 2014
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancerKelie M Reece, Emily D Richardson, Kristina M Cook, et al.
Circulation|December 13, 1997
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reactionK O Schowengerdt, J Ni, S W Denfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VIIA Wallgren, M Bonetti, R D Gelber, et al.
International Journal of Obesity (2005)|September 3, 2024
Metabolic adaptation following gastric bypass surgery: results from a 2-year observational studyFathimath Naseer, Shu-Dong Zhang, Alexander D Miras, et al.
Pageof 49